Sustained Efficacy of Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis Independent of Disease Activity and Disability at Baseline-Reference-Cited by-同舟云学术

Sustained Efficacy of Natalizumab in the Treatment of Relapsing-Remitting Multiple Sclerosis Independent of Disease Activity and Disability at Baseline

Published:2012-03 Issue:2 Volume:35 Page:77-80
ISSN:0362-5664
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:

Author:

Kallweit Ulf,Jelcic Ilijas,Braun Nathalie,Fischer Heike,Zörner Björn,Schreiner Bettina,Sokolov Arseny A.,Martin Roland,Weller Michael,Linnebank Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference10 articles.

1. . Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.;Havrdova;Lancet Neurol,2009

2. . A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.;Polman;N Engl J Med,2006

3. . Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study.;Oturai;Eur J Neurol,2009

4. . Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland.;Putzki;Eur Neurol,2010

5. . Natalizumab is effective in RRMS patients who do not respond to sequential therapy with interferon beta and glatiramer acetate: results of a switching study.;Memon;Neurology,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data Regarding Long-Term Administration of Natalizumab Derived from a Neurology Department along with Literature Review;CNS & Neurological Disorders - Drug Targets;2022-05

2. Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile;Arquivos de Neuro-Psiquiatria;2021-05

3. Effectiveness and Adverse Events of Use of Natalizumab in a Brazilian Cohort of Patients With Multiple Sclerosis;Clinical Therapeutics;2020-07

4. Do clinical trials for new disease modifying treatments include real world patients with multiple sclerosis?;Multiple Sclerosis and Related Disorders;2020-04

5. Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab;Multiple Sclerosis and Related Disorders;2019-08